Outcome of patients treated with pentostatin as salvage therapy of steroid refractory acute intestinal graft-versus-host disease

被引：0
|
作者：
Klein, SA [1 ]
Bug, G [1 ]
Wassmann, B [1 ]
Hoelzer, D [1 ]
Martin, H [1 ]
机构：
[1] Univ Frankfurt Klinikum, D-6000 Frankfurt, Germany
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [21] RETROSPECTIVE SINGLE CENTER ANALYSIS OF PENTOSTATIN FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Schmitt, T.
    Dietrich, S.
    Luft, T.
    Hegenbart, U.
    Ho, A. D.
    Dreger, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 57 - 58
  • [22] Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
    Khandelwal, Pooja
    Teusink-Cross, Ashley
    Davies, Stella M.
    Nelson, Adam S.
    Dandoy, Christopher E.
    El-Bietar, Javier
    Marsh, Rebecca A.
    Kumar, Ashish R.
    Grimley, Michael S.
    Jodele, Sonata
    Myers, Kasiani C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1122 - 1127
  • [23] Rituximab as salvage therapy for refractory chronic graft-versus-host disease
    Mohty, M.
    Marchetti, N.
    El-Cheikh, J.
    Faucher, C.
    Fuerst, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S231 - S231
  • [24] Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy
    Lee, H. J.
    Oran, B.
    Saliba, R. M.
    Couriel, D. M.
    Shin, K.
    Massey, P.
    Neumann, J.
    de Lima, M.
    Champlin, R.
    Giralt, S.
    BONE MARROW TRANSPLANTATION, 2006, 38 (04) : 299 - 303
  • [25] Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy
    H J Lee
    B Oran
    R M Saliba
    D M Couriel
    K Shin
    P Massey
    J Neumann
    M de Lima
    R Champlin
    S Giralt
    Bone Marrow Transplantation, 2006, 38 : 299 - 303
  • [26] Ten years single center experience on pentostatin as salvage therapy of steroid refractory acute graft versus host disease of the GI-tract
    Klein, S. A.
    Bug, G.
    Mousset, S.
    W-K, Hofmann
    Martin, H.
    ONKOLOGIE, 2010, 33 : 162 - 162
  • [27] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [28] Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Ming J. Poi
    Craig C. Hofmeister
    Jeffrey S. Johnston
    Ryan B. Edwards
    Buffy S. Jansak
    David M. Lucas
    Sherif S. Farag
    James T. Dalton
    Steven M. Devine
    Michael R. Grever
    Mitch A. Phelps
    Clinical Pharmacokinetics, 2013, 52 : 705 - 712
  • [29] Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Poi, Ming J.
    Hofmeister, Craig C.
    Johnston, Jeffrey S.
    Edwards, Ryan B.
    Jansak, Buffy S.
    Lucas, David M.
    Farag, Sherif S.
    Dalton, James T.
    Devine, Steven M.
    Grever, Michael R.
    Phelps, Mitch A.
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 705 - 712
  • [30] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Isshiki, Kyohei
    Kamiya, Takahiro
    Endo, Akifumi
    Okamoto, Kentaro
    Osumi, Tomoo
    Kawai, Toshinao
    Arai, Katsuhiro
    Tomizawa, Daisuke
    Ohtsuka, Kazuo
    Nagahori, Masakazu
    Imai, Kohsuke
    Kato, Motohiro
    Kanegane, Hirokazu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 590 - 594
12345